We identified on follow-up 68Ga-PSMA-11 PET/CT scans performed after ADT treatment, bone metastasis that reduced in density on the CT data, both in patients that responded to treatment and those that did not, but with variable intensity of 68Ga-PSMA-11 uptake on the PET data. The gene discussed is FOLH1; the disease is bone metastasis.